Positive Interim Results of CHOICE-01 Study Evaluating Coherus’ and Junshi Biosciences’ Toripalimab for First Line Treatment of Non-Small Cell Lung Cancer Presented at World Conference on Lung Cancer
REDWOOD CITY, Calif. and SHANGHAI, China , Sept. 13, 2021 (GLOBE NEWSWIRE) — Coherus Biosciences,…
Tokenwell Platforms Appoints Arif Shivji as Chief Financial Officer
Enablence Names Dr. James Gyarmathy as Chief Intelligence Officer
Enablence Names Dr. James Gyarmathy as Chief Intelligence Officer